Potential Molecular Mechanism of Upregulated Aryl Hydrocarbon Receptor Nuclear Translocator 2 in Nasopharyngeal Carcinoma
Open Access
- 27 September 2022
- journal article
- research article
- Published by Wiley in Computational and Mathematical Methods in Medicine
- Vol. 2022, 1-20
Abstract
Background. Currently, the benefits of nasopharyngeal carcinoma (NPC) therapy are limited, and it is necessary to further explore possible therapeutic targets. Aryl hydrocarbon receptor nuclear translocator 2 (ARNT2) has been extensively studied in other cancer species, but little has been explored in NPC. The aim of this study was to verify the expression level of ARNT2 and its underlying mechanism in NPC. Methods. Datasets containing ARNT2 mRNA expression levels were retrieved and collected from various databases to explore the expression status of ARNT2 in NPC. ARNT2-related coexpressed genes, differential expressed genes, and target genes were obtained for functional enrichment analysis. The potential target gene of ARNT2 and their regulatory relationship were studied through ChIP-seq data. CIBERSORTx was used to assess the immune infiltration of NPC, and the association with ARNT2 expression was calculated through correlation analysis. Results. ARNT2 was upregulated and possessed an excellent discriminatory capability in NPC samples. ARNT2 positively correlated target genes were clustered in pathways in cancer, while negatively correlated target genes were enriched in immune-related pathway. The ChIP-seq information of ARNT2 and histone showed that prostaglandin-endoperoxide synthase 2 (PTGS2) was a potential target gene of ARNT2. CIBERSORTx revealed the immunity status in NPC, and ARNT2 expression was correlated with infiltration of five immune cells. Conclusions. ARNT2 is overexpressed in NPC and may regulate PTGS2 to participate in the cancer process. ARNT2 serves as a key oncogenic target in NPC patients.Keywords
Funding Information
- Guangxi Medical High-level Key Talents Training “139” Program (2020, 2021B167, 2021JGA142, 2020JGA146, 2019XJGZ04, Z20201236, Z-A20220491)
- Guangxi Educational Science Planning Key Project (2020, 2021B167, 2021JGA142, 2020JGA146, 2019XJGZ04, Z20201236, Z-A20220491)
- Guangxi Higher Education Undergraduate Teaching Reform Project (2020, 2021B167, 2021JGA142, 2020JGA146, 2019XJGZ04, Z20201236, Z-A20220491)
- Guangxi Medical University (2020, 2021B167, 2021JGA142, 2020JGA146, 2019XJGZ04, Z20201236, Z-A20220491)
- Guangxi Zhuang Autonomous Region Health Commission Self-financed Scientific Research Project (2020, 2021B167, 2021JGA142, 2020JGA146, 2019XJGZ04, Z20201236, Z-A20220491)
This publication has 31 references indexed in Scilit:
- Fine Particulate Matter (PM2.5) Promoted the Invasion of Lung Cancer Cells via an ARNT2/PP2A/STAT3/MMP2 PathwayJournal of Biomedical Nanotechnology, 2018
- Expression of the neuroprotective protein aryl hydrocarbon receptor nuclear translocator 2 correlates with neuronal stress and disability in models of multiple sclerosisJournal of Neuroinflammation, 2018
- High COX-2 expression contributes to a poor prognosis through the inhibition of chemotherapy-induced senescence in nasopharyngeal carcinomaInternational Journal of Oncology, 2018
- Overexpression of ARNT2 is associated with decreased cell proliferation and better prognosis in gastric cancerMolecular and Cellular Biochemistry, 2018
- Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressivenessActa Neuropathologica, 2017
- ARNT2 Regulates Tumoral Growth in Oral Squamous Cell CarcinomaJournal of Cancer, 2016
- COX-2 promotes metastasis in nasopharyngeal carcinoma by mediating interactions between cancer cells and myeloid-derived suppressor cellsOncoImmunology, 2015
- Downregulation of ARNT2 promotes tumor growth and predicts poor prognosis in human hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2015
- More targets, more pathways and more clues for mutant p53Oncogenesis, 2013
- siRNA-mediated knockdown of aryl hydrocarbon receptor nuclear translocator 2 affects hypoxia-inducible factor-1 regulatory signaling and metabolism in human breast cancer cellsFEBS Letters, 2011